Skanska signs additional contract for new hospital in Fort Myers, Florida, USA, for USD 60M, about SEK 560M

By Cision
Skanska

Skanska has signed an additional contract with Lee Health for the construction of a new hospital and medical office building in Fort Myers, Florida, USA. The additional contract is worth USD 60M, about SEK 560M, which will be included in the US order bookings for the third quarter of 2026.

The full project contract was amended to include interior build-out finishes, and mechanical, electrical and plumping work associated with the West Bed Tower expansion. The full project scope includes constructing an approximately 38,600 square-meter (416,000-square-foot), five-story hospital, a central energy plant, and an approximately 11,600 square-meter (125,000-square-foot) medical office building which includes an ambulatory surgery center.

Construction began in June 2024 and is scheduled for completion in May 2028.

For further information please contact:

Jessica Wheeler, Communications Director Southeast, Skanska USA, tel +1 919 717 3429

Andreas Joons, Press Officer, Skanska AB, tel +46 76 870 75 51

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com/group.

Skanska Group uses its knowledge and foresight to shape the way people live, work, and connect. We are one of the world's largest construction and project development companies, with 2025 revenue totaling SEK 179 billion. We operate across select markets in the Nordics, Europe and USA. Together with our customers and the collective expertise of our approximately 25,900 teammates, we create innovative and sustainable solutions that support healthy living beyond our lifetime.

https://news.cision.com/skanska/r/skanska-signs-additional-contract-for-new-hospital-in-fort-myers--florida--usa--for-usd-60m--about-s%2Cc4403719

20261002 US additional hospital contract

Image US hospital Fort Myers

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.